156 related articles for article (PubMed ID: 30903640)
21. Intratumoral therapy with IL13-PE38 results in effective CTL-mediated suppression of IL-13Ralpha2-expressing contralateral tumors.
Kawakami K; Terabe M; Kioi M; Berzofsky JA; Puri RK
Clin Cancer Res; 2006 Aug; 12(15):4678-86. PubMed ID: 16899618
[TBL] [Abstract][Full Text] [Related]
22. Novel recombinant adenoviral vector that targets the interleukin-13 receptor alpha2 chain permits effective gene transfer to malignant glioma.
Ulasov IV; Tyler MA; Han Y; Glasgow JN; Lesniak MS
Hum Gene Ther; 2007 Feb; 18(2):118-29. PubMed ID: 17328684
[TBL] [Abstract][Full Text] [Related]
23. Mechanical stretch and angiotensin II increase interleukin-13 production and interleukin-13 receptor alpha2 expression in rat neonatal cardiomyocytes.
Nishimura Y; Inoue T; Morooka T; Node K
Circ J; 2008 Apr; 72(4):647-53. PubMed ID: 18362439
[TBL] [Abstract][Full Text] [Related]
24. IL-13Rα2 mediates PNR-induced migration and metastasis in ERα-negative breast cancer.
Zhao Z; Wang L; Xu W
Oncogene; 2015 Mar; 34(12):1596-607. PubMed ID: 24747967
[TBL] [Abstract][Full Text] [Related]
25. Interleukin-13 receptor alpha 2 cooperates with EGFRvIII signaling to promote glioblastoma multiforme.
Newman JP; Wang GY; Arima K; Guan SP; Waters MR; Cavenee WK; Pan E; Aliwarga E; Chong ST; Kok CYL; Endaya BB; Habib AA; Horibe T; Ng WH; Ho IAW; Hui KM; Kordula T; Lam PYP
Nat Commun; 2017 Dec; 8(1):1913. PubMed ID: 29203859
[TBL] [Abstract][Full Text] [Related]
26. IL-13Rα2 Status Predicts GB-13 (IL13.E13K-PE4E) Efficacy in High-Grade Glioma.
Rechberger JS; Porath KA; Zhang L; Nesvick CL; Schrecengost RS; Sarkaria JN; Daniels DJ
Pharmaceutics; 2022 Apr; 14(5):. PubMed ID: 35631512
[TBL] [Abstract][Full Text] [Related]
27. Identification of a human leukocyte antigen-A24-restricted T-cell epitope derived from interleukin-13 receptor alpha2 chain, a glioma-associated antigen.
Shimato S; Natsume A; Wakabayashi T; Tsujimura K; Nakahara N; Ishii J; Ito M; Akatsuka Y; Kuzushima K; Yoshida J
J Neurosurg; 2008 Jul; 109(1):117-22. PubMed ID: 18590440
[TBL] [Abstract][Full Text] [Related]
28. Cigarette smoke extracts induce overexpression of the proto-oncogenic gene interleukin-13 receptor α2 through activation of the PKA-CREB signaling pathway to trigger malignant transformation of lung vascular endothelial cells and angiogenesis.
Meng M; Liao H; Zhang B; Pan Y; Kong Y; Liu W; Yang P; Huo Z; Cao Z; Zhou Q
Cell Signal; 2017 Feb; 31():15-25. PubMed ID: 27986643
[TBL] [Abstract][Full Text] [Related]
29. Expression of IL-13Ralpha2 in liver cancer cells and its effect on targeted therapy of liver cancer.
Hou L; Du J; Wang J; Liu Y; Sun W; Zheng Y; Zhang L; Hu H; Dai X; Guan W; Ma Y; Hong T
J Cancer Res Clin Oncol; 2010 Jun; 136(6):839-46. PubMed ID: 19916021
[TBL] [Abstract][Full Text] [Related]
30. IL13RA2 targeted alpha particle therapy against glioblastomas.
Sattiraju A; Solingapuram Sai KK; Xuan A; Pandya DN; Almaguel FG; Wadas TJ; Herpai DM; Debinski W; Mintz A
Oncotarget; 2017 Jun; 8(26):42997-43007. PubMed ID: 28562337
[TBL] [Abstract][Full Text] [Related]
31. IL-13Rα2 uses TMEM219 in chitinase 3-like-1-induced signalling and effector responses.
Lee CM; He CH; Nour AM; Zhou Y; Ma B; Park JW; Kim KH; Dela Cruz C; Sharma L; Nasr ML; Modis Y; Lee CG; Elias JA
Nat Commun; 2016 Sep; 7():12752. PubMed ID: 27629921
[TBL] [Abstract][Full Text] [Related]
32. Induction of cytotoxic T lymphocytes specific to malignant glioma using T2 cells pulsed with HLA-A2-restricted interleukin-13 receptor alpha 2 peptide in vitro.
Jiang X; Lu X; Liu R; Zhang F; Zhao H
Acta Biochim Biophys Sin (Shanghai); 2007 Sep; 39(9):641-8. PubMed ID: 17805458
[TBL] [Abstract][Full Text] [Related]
33. Nanoparticles functionalized with Pep-1 as potential glioma targeting delivery system via interleukin 13 receptor α2-mediated endocytosis.
Wang B; Lv L; Wang Z; Zhao Y; Wu L; Fang X; Xu Q; Xin H
Biomaterials; 2014 Jul; 35(22):5897-907. PubMed ID: 24743033
[TBL] [Abstract][Full Text] [Related]
34. Targeting interleukin-4 receptor alpha by hybrid Peptide for novel biliary tract cancer therapy.
Seto K; Shoda J; Horibe T; Warabi E; Kohno M; Yanagawa T; Bukawa H; Nakanuma Y; Kawakami K
Int J Hepatol; 2014; 2014():584650. PubMed ID: 24868471
[TBL] [Abstract][Full Text] [Related]
35. Recent Advances in IL-13Rα2-Directed Cancer Immunotherapy.
Knudson KM; Hwang S; McCann MS; Joshi BH; Husain SR; Puri RK
Front Immunol; 2022; 13():878365. PubMed ID: 35464460
[TBL] [Abstract][Full Text] [Related]
36. Gastrodin synergistically increases migration of interleukin-13 receptor α2 chimeric antigen receptor T cell to the brain against glioblastoma multiforme: A preclinical study.
Huang S; Bai Y; An Z; Xu C; Zhang C; Wang F; Zhong C; Zhong X
Phytother Res; 2023 Dec; 37(12):5947-5957. PubMed ID: 37748098
[TBL] [Abstract][Full Text] [Related]
37. Analysis of antitumor activity of an interleukin-13 (IL-13) receptor-targeted cytotoxin composed of IL-13 antagonist and Pseudomonas exotoxin.
Kioi M; Kawakami K; Puri RK
Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6231-8. PubMed ID: 15448012
[TBL] [Abstract][Full Text] [Related]
38. Anti-IL-13Rα2 therapy promotes recovery in a murine model of inflammatory bowel disease.
Karmele EP; Pasricha TS; Ramalingam TR; Thompson RW; Gieseck RL; Knilans KJ; Hegen M; Farmer M; Jin F; Kleinman A; Hinds DA; ; Almeida Pereira T; de Queiroz Prado R; Bing N; Tchistiakova L; Kasaian MT; Wynn TA; Vannella KM
Mucosal Immunol; 2019 Sep; 12(5):1174-1186. PubMed ID: 31308480
[TBL] [Abstract][Full Text] [Related]
39. The association of the cytoplasmic domains of interleukin 4 receptor alpha and interleukin 13 receptor alpha 2 regulates interleukin 4 signaling.
Andrews AL; Nordgren IK; Campbell-Harding G; Holloway JW; Holgate ST; Davies DE; Tavassoli A
Mol Biosyst; 2013 Dec; 9(12):3009-14. PubMed ID: 24056919
[TBL] [Abstract][Full Text] [Related]
40. In vitro and in vivo intracellular distribution and anti-glioblastoma effects of docetaxel-loaded nanoparticles functioned with IL-13 peptide.
Gao H; Zhang S; Yang Z; Cao S; Jiang X; Pang Z
Int J Pharm; 2014 May; 466(1-2):8-17. PubMed ID: 24607217
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
